264 related articles for article (PubMed ID: 17237623)
21. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo.
Hershberger PA; Modzelewski RA; Shurin ZR; Rueger RM; Trump DL; Johnson CS
Cancer Res; 1999 Jun; 59(11):2644-9. PubMed ID: 10363987
[TBL] [Abstract][Full Text] [Related]
22. Increased cdc2 and cdk2 kinase activity by retinoid X receptor gamma-mediated transcriptional down-regulation of the cyclin-dependent kinase inhibitor p21Cip1/WAF1 correlates with terminal differentiation of squamous cell carcinoma lines.
Crowe DL; Shuler CF
Cell Growth Differ; 1998 Aug; 9(8):619-27. PubMed ID: 9716179
[TBL] [Abstract][Full Text] [Related]
23. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase.
Chiang KC; Yeh CN; Hsu JT; Chen LW; Kuo SF; Sun CC; Huang CC; Pang JH; Flanagan JN; Takano M; Kittaka A; Juang HH; Yang SW; Chen TC
J Steroid Biochem Mol Biol; 2013 Nov; 138():427-34. PubMed ID: 24044969
[TBL] [Abstract][Full Text] [Related]
24. Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells.
Chung I; Wong MK; Flynn G; Yu WD; Johnson CS; Trump DL
Cancer Res; 2006 Sep; 66(17):8565-73. PubMed ID: 16951169
[TBL] [Abstract][Full Text] [Related]
25. Effects of vitamin D analogs on the expression of plasminogen activator inhibitor-1 in human vascular cells.
Wu-Wong JR; Nakane M; Ma J
Thromb Res; 2006; 118(6):709-14. PubMed ID: 16371233
[TBL] [Abstract][Full Text] [Related]
26. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
27. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
28. 24-Oxo metabolites of vitamin D3 analogues: disassociation of their prominent antileukemic effects from their lack of calcium modulation.
Shiohara M; Uskokovic M; Hisatake J; Hisatake Y; Koike K; Komiyama A; Koeffler HP
Cancer Res; 2001 Apr; 61(8):3361-8. PubMed ID: 11309293
[TBL] [Abstract][Full Text] [Related]
29. Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1.
Aguero MF; Facchinetti MM; Sheleg Z; Senderowicz AM
Cancer Res; 2005 Apr; 65(8):3364-73. PubMed ID: 15833870
[TBL] [Abstract][Full Text] [Related]
30. ZK 156718, a low calcemic, antiproliferative, and prodifferentiating vitamin D analog.
Gaschott T; Steinmeyer A; Steinhilber D; Stein J
Biochem Biophys Res Commun; 2002 Jan; 290(1):504-9. PubMed ID: 11779200
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects.
Campbell MJ; Reddy GS; Koeffler HP
J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197
[TBL] [Abstract][Full Text] [Related]
32. Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model.
Park MR; Lee JH; Park MS; Hwang JE; Shim HJ; Cho SH; Chung IJ; Bae WK
J Korean Med Sci; 2012 Sep; 27(9):1037-43. PubMed ID: 22969249
[TBL] [Abstract][Full Text] [Related]
33. Terbinafine inhibits oral squamous cell carcinoma growth through anti-cancer cell proliferation and anti-angiogenesis.
Chien MH; Lee TS; Kao C; Yang SF; Lee WS
Mol Carcinog; 2012 May; 51(5):389-99. PubMed ID: 21563217
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.
Brard L; Lange TS; Robison K; Kim KK; Ara T; McCallum MM; Arnold LA; Moore RG; Singh RK
Gynecol Oncol; 2011 Nov; 123(2):370-8. PubMed ID: 21803404
[TBL] [Abstract][Full Text] [Related]
35. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
[TBL] [Abstract][Full Text] [Related]
37. Differential photoprotective effects of 1,25-dihydroxyvitamin D3 and a low calcaemic deltanoid.
Dixon KM; Sequeira VB; Deo SS; Mohan R; Posner GH; Mason RS
Photochem Photobiol Sci; 2012 Dec; 11(12):1825-30. PubMed ID: 22907250
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
[TBL] [Abstract][Full Text] [Related]
39. Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs.
Dixon KM; Deo SS; Wong G; Slater M; Norman AW; Bishop JE; Posner GH; Ishizuka S; Halliday GM; Reeve VE; Mason RS
J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):137-43. PubMed ID: 16039116
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells.
Bernardi RJ; Johnson CS; Modzelewski RA; Trump DL
Endocrinology; 2002 Jul; 143(7):2508-14. PubMed ID: 12072382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
